TITLE

A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis

AUTHOR(S)
SHERGILL, SUKHWINDER S.; WALKER, ZUZANA; LE KATONA, CORNELIUS; Shergill, S S; Walker, Z; Le Katona, C
PUB. DATE
October 1998
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Oct1998, Vol. 65 Issue 4, p610
SOURCE TYPE
Academic Journal
DOC. TYPE
letter
ABSTRACT
No abstract available.
ACCESSION #
66329609

 

Related Articles

  • Psychosis in Parkinson's disease. Thanvi, B. R.; Lo, T. C. N.; Harsh, D. P. // Postgraduate Medical Journal;Oct2005, Vol. 81 Issue 960, p644 

    Psychosis is common in Parkinson's disease (PD), particularly in its later stages. The symptoms range from comparatively minor illusions, vivid dreams, and occasional, non-disturbing visual hallucinations to frank psychosis. The pathogenesis of psychosis in PD is not fully known. Management of...

  • Ziprasidone in Parkinson's disease psychosis. Connemann, Bernhard J.; Schönfeldt-Lecuona, Carlos // Canadian Journal of Psychiatry;Jan2004, Vol. 49 Issue 1, p73 

    Presents a letter to the editor concerning the use of ziprasidone in treating Parkinson's disease psychosis.

  • Parkinson's Disease Update.  // PharmaWatch: CNS;August 2005, Vol. 4 Issue 8, p7 

    The article presents information about recent developments related to Parkinson' disease. Acadia Pharmaceuticals Inc. has received encouraging preliminary results from an ongoing clinical trial which show the company's serotonin acting drug, ACP-103, can help reduce symptoms of treatment-induced...

  • A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. Poletti, Michele; Frosini, Daniela; Pagni, Cristina; Baldacci, Filippo; Lucetti, Claudio; Dotto, Paolo; Ceravolo, Roberto; Bonuccelli, Ubaldo // Neurological Sciences;Oct2014, Vol. 35 Issue 10, p1603 

    An overactive striatal dopaminergic neurotransmission is described in psychosis and may be associated with a state of aberrant salience attribution. This pilot psychometric study investigated if features suggestive of an aberrant salience state, a condition of psychosis proneness, are associated...

  • C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population. Cannas, Antonino; Solla, Paolo; Borghero, Giuseppe; Floris, Gian; Chio, Adriano; Mascia, Marcello; Modugno, Nicola; Muroni, Antonella; Orofino, Gianni; Stefano, Francesca; Calvo, Andrea; Moglia, Cristina; Restagno, Gabriella; Meloni, Mario; Farris, Rita; Ciaccio, Daniela; Puddu, Roberta; Vacca, Melisa; Melis, Rosanna; Murru, Maria // Journal of Neurology;Nov2015, Vol. 262 Issue 11, p2498 

    The hexanucleotide repeat expansion GGGGCC in the C9ORF72 gene larger than 30 repeats has been identified as a major genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recent papers investigated the possible pathogenic role and associated clinical phenotypes...

  • Pathophysiology and Treatment of Psychosis in ParkinsonÂ’s Disease: A Review. Zahodne, Laura B.; Fernandez, Hubert H. // Drugs & Aging;2008, Vol. 25 Issue 8, p665 

    Psychotic symptoms in ParkinsonÂ’s disease (PD) are relatively common and, in addition to creating a disturbance in patientsÂ’ daily lives, have consistently been shown to be associated with poor outcome. Our understanding of the pathophysiology of psychosis in PD has expanded dramatically...

  • Enhanced frontal function in Parkinson’s disease. Cools, R.; Miyakawa, A.; Sheridan, M.; D'Esposito, M. // Brain: A Journal of Neurology;Jan2010, Vol. 133 Issue 1, p225 

    We investigated the role of dopamine in working memory by examining effects of withdrawing dopaminergic medication in patients with Parkinson’s disease. Resistance to distraction during a delayed response task was abnormally enhanced in Parkinson’s disease patients OFF medication...

  • Levodopa.  // Reactions Weekly;5/8/2004, Issue 1000, p10 

    Describes a case report on the side effects of the drug levodopa on an elderly patient with Parkinson's disease. Development of psychosis in the patient; Drug dosage received by the patient; Information on the Uniform Parkinson Disease Rating Scale score of the patient.

  • AT A GLANCE Parkinson's disease.  // GP: General Practitioner;11/11/2002, p67 

    Focuses on Parkinson's disease. Clinical features of the disease; Investigation of the disease; Treatment of Parkinson's disease.

  • Parkinsonism.  // Columbia Electronic Encyclopedia, 6th Edition;Feb2013, p1 

    Parkinsonism: see Parkinson's disease.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics